Key US senator investigates fda over rare-disease drug denials

Senator to Investigate FDA Rejections of Rare Disease Drugs

(MedPage Today) -- Sen. Ron Johnson (R-Wisc.) said Tuesday he would begin an investigation into the FDA's handling of approval applications for biologic therapies to treat Duchenne muscular dystrophy (DMD) and other rare life-threatening disorders...

GOP senator is investigating the FDA over rejections of rare disease drugs

Sen. Ron Johnson has long been an advocate for giving people with rare diseases speedy access to experimental treatments.

Republican launches investigation into Trump admin FDA denials

Senator Ron Johnson said he's launched an investigation into the FDA over the agency's recent denials of treatments for rare diseases.

Key US senator investigates fda over rare-disease drug denials

WASHINGTON — A key U.S. Republican senator said he’s launched an investigation into the Food and Drug Administration’s recent denials of treatments for rare diseases, adding political pressure on an agency that’s already in turmoil.